☆ 4.5 Article

Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event

JOURNAL OF CARDIAC FAILURE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary

Paul A. Heidenreich et al.

Summary: The 2022 heart failure guideline aims to provide recommendations for the prevention, diagnosis, and treatment of patients with heart failure. Based on contemporary evidence, the guideline seeks to improve quality of care and align with patients' interests.

JOURNAL OF CARDIAC FAILURE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF

Muthiah Vaduganathan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan The PARADIGM-HF Trial

Peder Langeland Myhre et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

Rolf Wachter et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial

David A. Morrow et al.

CIRCULATION (2019)

添加到收藏夹

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

S. D. Solomon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure

Eric J. Velazquez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

The vulnerable phase after hospitalization for heart failure

Stephen J. Greene et al.

NATURE REVIEWS CARDIOLOGY (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

Soren L. Kristensen et al.

JACC-HEART FAILURE (2015)

添加到收藏夹

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure

John J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Scott D. Solomon et al.

LANCET (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.